837 results on '"Katz, Matthew H G"'
Search Results
2. Operative Standards for Cancer Care: One Step at a Time
3. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)
4. Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery
5. Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)
6. Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma
7. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
8. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis
9. ASO Visual Abstract: Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)
10. Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy
11. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy
12. Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center
13. What Defines the Value of Minimally Invasive Surgery for Cancer Patients?
14. Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study
15. ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA
16. ASO Visual Abstract: Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery
17. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
18. Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
19. Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria
20. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma
21. Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy
22. ASO Visual Abstract: Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy
23. Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
24. Response to: Comment on “Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial”
25. ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9
26. ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment—A TAPS Consortium Study
27. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial
28. Neoadjuvant therapy for pancreatic cancer
29. FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review
30. Shifting the Focus: Value-Based Care in Surgical Oncology
31. ASO Visual Abstract: Standardization of Colon Resection for Cancer—An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
32. Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer
33. Minimally Invasive Surgical Approaches
34. What is “Value”? Results of a Survey of Cancer Patients and Providers
35. Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3–5.8
36. Racial disparities in receipt of guideline concordant pancreatic cancer care among older adults in the US.
37. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
38. ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review
39. Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy
40. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution
41. PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
42. Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy
43. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis
44. Cooperative Clinical Trials
45. The Landmark Series: Preoperative Therapy for Pancreatic Cancer
46. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma
47. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.
48. Transmesocolic Approach for Robotic Duodenal Operations
49. Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study
50. Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.